Total Payments
$458.88
2020 Payments
$90.20
Companies
12
Transactions
25
Medicare Patients
252
Medicare Billing
$7,384
Payment Breakdown by Category
Food & Beverage$458.88 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $458.88 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $142.14 | 8 | $0 (2020) |
| Amgen Inc. | $59.62 | 3 | $0 (2020) |
| Rochester Medical Corporation | $55.55 | 2 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $38.66 | 2 | $0 (2019) |
| Boston Scientific Corporation | $36.55 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $33.14 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.08 | 1 | $0 (2019) |
| Avadel Specialty Pharmaceuticals, LLC | $18.76 | 1 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $17.81 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $13.32 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $90.20 | 5 | Amgen Inc. ($59.62) |
| 2019 | $157.44 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($38.66) |
| 2018 | $70.55 | 4 | Astellas Pharma US Inc ($51.79) |
| 2017 | $140.69 | 6 | Rochester Medical Corporation ($55.55) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2020 | Amgen Inc. | KANJINTI (Biological), MVASI, Neulasta | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Oncology | ||||||
| 02/18/2020 | Amgen Inc. | KANJINTI (Biological), MVASI, Neulasta | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Oncology | ||||||
| 02/11/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Oncology | ||||||
| 01/31/2020 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Bone Health | ||||||
| 01/24/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $14.28 | General |
| 09/20/2019 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ, ROZLYTREK | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: BioOncology | ||||||
| 09/16/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: UROLOGY | ||||||
| 08/09/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Oncology | ||||||
| 06/04/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 04/22/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $13.27 | General |
| 04/12/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Oncology | ||||||
| 04/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2019 | Boston Scientific Corporation | GENERAL BPH (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: BPH | ||||||
| 01/18/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug), Aliqopa | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Oncology | ||||||
| 11/05/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Urology | ||||||
| 02/07/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug), XTANDI, VESICARE | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: UROLOGY | ||||||
| 01/04/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: UROLOGY | ||||||
| 11/14/2017 | Rochester Medical Corporation | BMD-Magic3 Catheter (Device) | Food and Beverage | Cash or cash equivalent | $38.15 | General |
| Category: Urology | ||||||
| 11/06/2017 | BOSTON SCIENTIFIC CORPORATION | LITHOVUE (Device) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: SCOPE | ||||||
| 10/23/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare, Xtandi | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Urology | ||||||
| 09/20/2017 | Rochester Medical Corporation | BMD-Magic3 Catheter (Device) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Urology | ||||||
| 09/11/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Gout/Rheumatology | ||||||
| 06/05/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 8 | 252 | 280 | $45,492 | $7,384 |
Total Patients
252
Total Services
280
Medicare Billing
$7,384
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 25 | 25 | $12,627 | $1,971 | 15.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 54 | $12,321 | $1,947 | 15.8% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 11 | 11 | $6,622 | $1,155 | 17.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 13 | $2,990 | $802.88 | 26.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 46 | 49 | $6,741 | $551.00 | 8.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 15 | $2,093 | $468.74 | 22.4% |
| 81002 | Urinalysis, manual test | Office | 2020 | 63 | 77 | $803.88 | $263.27 | 32.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 32 | 36 | $1,295 | $224.44 | 17.3% |
About Dr. Ranjit Jain, M.D
Dr. Ranjit Jain, M.D is a Urology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053374744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ranjit Jain, M.D has received a total of $458.88 in payments from pharmaceutical and medical device companies, with $90.20 received in 2020. These payments were reported across 25 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($458.88).
As a Medicare-enrolled provider, Jain has provided services to 252 Medicare beneficiaries, totaling 280 services with total Medicare billing of $7,384. Data is available for 1 year (2020–2020), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Las Vegas, NV
- Active Since 04/11/2006
- Last Updated 01/31/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1053374744
Products in Payments
- BMD-Magic3 Catheter (Device) $55.55
- KANJINTI (Biological) $40.73
- MYRBETRIQ (Drug) $34.34
- EMPLICITI (Biological) $33.14
- XTANDI (Drug) $30.43
- Xtandi (Drug) $23.85
- Myrbetriq (Drug) $21.84
- LITHOVUE (Device) $21.64
- Vitrakvi (Drug) $19.68
- GILOTRIF (Drug) $19.08
- Xofigo (Drug) $18.98
- Prolia (Biological) $18.89
- Noctiva (Drug) $18.76
- Uloric (Drug) $17.81
- VESICARE (Drug) $17.40
- GENERAL BPH (Device) $14.91
- ERLEADA (Drug) $13.32
- Alecensa (Biological) $10.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Las Vegas
Vijay Goli, M.d, M.D
Urology — Payments: $322,441
Urology $322,441
Joel Abbott, D.o, D.O
Urology — Payments: $115,145
Urology $115,145
Victor Grigoriev, M.d, M.D
Urology — Payments: $75,593
Urology $75,593
Omid Lesani, M.d, M.D
Urology — Payments: $52,856
Urology $52,856
Sheldon Freedman, Md, MD
Urology — Payments: $43,617
Urology $43,617
Michael Verni, M.d, M.D
Urology — Payments: $42,412
Urology $42,412